Cart
sales@molnova.com
GSK-2636771
CAS No. 1372540-25-4
GSK-2636771 ( —— )
Catalog No. M11535 CAS No. 1372540-25-4
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 47 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 138 | In Stock |
|
| 25MG | 240 | In Stock |
|
| 50MG | 340 | In Stock |
|
| 100MG | 518 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-2636771
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
-
DescriptionGSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kβ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1372540-25-4
-
Formula Weight433.42
-
Molecular FormulaC22H22F3N3O3
-
Purity>98%(HPLC)
-
SolubilityDMSO: 28 mg/mL (64.6 mM)
-
SMILESCC1=NC2=C(C=C(C=C2C(O)=O)N2CCOCC2)N1CC1=C(C)C(=CC=C1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Macauley D, et al. Drugs Fut, 2012, 37(6), 45
molnova catalog
related products
-
LY3023414
LY3023414 is a potent, dual PI3K/mTOR inhibitor.
-
INCB040093
A novel potent, selective, orally available PI3Kδ inhibitor with IC50 of 31 nM.
-
MOMIPP
MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts.
